Site Editor

Robert I. Haddad, MD

Advertisement

Advertisement

JNCCN Spotlights

Selpercatinib (Retevmo™)

Videos

Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer

News

Are Serum Thyroglobulin Levels a Reliable Marker of Recurrence in Thyroid Cancer?

Medical Literature

Gallium-68 DOTATATE PET-CT for Medullary Thyroid Cancer

JNCCN Spotlights

Dabrafenib + Trametinib (Anaplastic Thyroid Cancer)

News

ASTRO 2020: High-Dose Iodine-131 Ablation for High-Risk Thyroid Cancer

News

ASTRO 2020: Locoregional Failure Patterns With IMRT for Anaplastic Thyroid Cancer

Lori J. Wirth, MD, on RET-Altered Thyroid Cancer: Results From a Study on Selpercatinib

The JNCCN Spotlight

View More

Advertisement

JNCCN Spotlights

Dabrafenib + Trametinib (Anaplastic Thyroid Cancer)

Selpercatinib (Retevmo™)

View More

More

News

ESMO 2020: Influence of Selpercatinib on Diarrhea in Patients With Medullary Thyroid Cancer

Refining Outcome Prognostication After Initial Treatment of Differentiated Thyroid Cancer

ASTRO 2020: Locoregional Failure Patterns With IMRT for Anaplastic Thyroid Cancer

ASTRO 2020: Does a Reduced Radiation Field Decrease Toxicity in Advanced Thyroid Cancer?

ESMO 2020: Nintedanib in Progressive Medullary Thyroid Cancer

ESMO 2020: Lenvatinib Plus Pembrolizumab in Metastatic Thyroid Carcinoma

Are Serum Thyroglobulin Levels a Reliable Marker of Recurrence in Thyroid Cancer?

Lenvatinib in Advanced Anaplastic Thyroid Cancer: Real-World Setting

View More

Advertisement

Published

Medical Literature

Using Carbon Nanoparticles to Map Lateral Neck Lymph Nodes in Papillary Thyroid Cancer

Total Versus Partial Thyroidectomy for Early-Stage Papillary Thyroid Cancer

Use of Opioids in Patients With Thyroid Cancer After Extensive Neck Dissection

Using AI to Determine the Genetic Risk of Thyroid Nodules

View More

Ongoing

CE Activities

Differentiated thyroid cancer (DTC): therapeutic updates and optimizing treatment

A Unique Approach to Assessing the Risk of Indeterminate Thyroid Nodules

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma

Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?

View More

Available

Clinical Trials

Memorial Sloan Kettering Memorial Center

Samuel Oschin Comprehensive Cancer Center

Yale Cancer Center

University of Michigan Rogel Cancer Center

View More

Resources

For Your Patients

ThyCa: Thyroid Cancer Survivors' Association, Inc.

American Thyroid Association

Rogel Cancer Center Thyroid Cancer Patient Resources

Light of Life Foundation

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.